-Livemint.com After being on the sidelines of Dalit and feminist movements for long, Dalit women are now standing up for their rights New Delhi: In 2008, seven women, aged 19-24, walked into a police station in Haryana’s Indri village in Kurukshetra district. Dressed in salwar-kameez with dupattas draped around their necks, they looked tired but confident, angry and brimming with questions. They wanted to meet the SHO and ask why no FIR...
More »SEARCH RESULT
We'll strike down any law that violates rights, says SC -Dhananjay Mahapatra
-The Times of India NEW DELHI: Reserving its verdict on pleas seeking decriminalisation of Section 377 of the IPC to protect sexual orientation of LGBTs, the Supreme Court refused to leave the matter to Parliament and asserted its right on Tuesday to overturn and change Laws enacted by a majority government if they were violative of fundamental rights. A bench of Chief Justice Dipak Misra and Justices R F Nariman, A M...
More »A silent emergency -Oommen C Kurian
-The Indian Express Rising cases of leprosy among Adivasis call for urgent public action. India officially eliminated Leprosy in 2005 by bringing the Prevalence Rate below 1/10000 at the national level. However, the National Health Policy 2017 (NHP), which will guide the health policy direction of the country over the next decade or so, still has elimination of Leprosy as a national level target. It is highly unlikely that India achieves elimination...
More »Finance ministry's own division shares EC's concerns on electoral bonds & transparency -Sanya Dhingra
-ThePrint.in The Financial Sector Reforms and Legislation Division has agreed with the EC’s view, which is that the new Laws are ‘retrograde’ and need to be withdrawn. New Delhi: The Election Commission’s concerns over the transparency of electoral bonds, introduced via the Finance Act, 2017, have been supported by the Financial Sector Reforms and Legislation Division of the finance ministry. According to an RTI filed by activist Commodore Lokesh Batra (retd), an official...
More »Patent challenge to hepatitis-C medicines
-The Telegraph New Delhi: Patients' rights advocates in India on Tuesday filed two oppositions in the Indian patent office, challenging patent claims by the US pharmaceutical company Gilead Sciences for its medicines sofosbuvir and velpatasvir, used to treat hepatitis-C infections. The oppositions filed by the Delhi Network of Positive People (DNP+) challenge Gilead's patent applications for the tablet formulations of the fixed dose combination of sofosbuvir and velpatasvir and a new form...
More »